EcoDrugPlus

Calcium Voltage-Gated Channel Subunit Alpha1 I

Ensembl ID : ENSAOCG00000001236
Gene Symbol: CACNA1I
3 Cross references
206 Possible Orthologues:

Calcium Voltage-Gated Channel Subunit Alpha1 S

Ensembl ID : ENSAOCG00000003524
Gene Symbol: CACNA1S
3 Cross references
196 Possible Orthologues:

Cannabinoid Receptor 1

Ensembl ID : ENSAOCG00000004388
Gene Symbol: CNR1
3 Cross references
154 Possible Orthologues:

Cannabinoid Receptor 2

Ensembl ID : ENSAOCG00000009659
Gene Symbol: CNR2
1 Cross references
196 Possible Orthologues:

Carbonic Anhydrase 12

Ensembl ID : ENSAOCG00000018504
Gene Symbol: CA12
3 Cross references
215 Possible Orthologues:

Carbonic Anhydrase 4

Ensembl ID : ENSAOCG00000022543
Gene Symbol: CA4
3 Cross references
215 Possible Orthologues:

Carbonic Anhydrase 4-Like

Ensembl ID : ENSAOCG00000021506
Gene Symbol: LOC111580879
3 Cross references
201 Possible Orthologues:

Carbonic Anhydrase 5b, Mitochondrial-Like

Ensembl ID : ENSAOCG00000018852
Gene Symbol: LOC111568670
3 Cross references
231 Possible Orthologues:

Carbonic Anhydrase 6

Ensembl ID : ENSAOCG00000012917
Gene Symbol: CA6
3 Cross references
227 Possible Orthologues:

Carbonic Anhydrase 7

Ensembl ID : ENSAOCG00000003675
Gene Symbol: CA7
3 Cross references
222 Possible Orthologues:

Carbonic Anhydrase Xiv

Ensembl ID : ENSAOCG00000011538
Gene Symbol: CA14
1 Cross references
211 Possible Orthologues:

Casein Kinase 1 Epsilon

Ensembl ID : ENSAOCG00000003246
Gene Symbol: CSNK1E
3 Cross references
199 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).